Non-invasive CGM
using AI
Continuously monitor the blood glucose level using digital bio-marker.
Gestational diabetes
Empowering mothers with health and mental well-being with our AI powered non-invasive CGM
Pain points and risks
- Tracking numerous health complications during pregnancy is crucial for both maternal and child health.
- Common complications include diabetes, mental health conditions, hypertension, anemia, infections, and obesity.
- While early detection can prevent diabetes during pregnancy, there is found a significant lack of awareness and education on this issue.
Pregnant women lack the necessary support to prevent and manage these conditions."
Women with gestational diabetes have a 50% risk of developing type 2 diabetes post-pregnancy.
Problems of gestational diabetes
- Large size, complicating delivery
- Preterm birth, leading to respiratory and other issues.
- Low blood sugar
- Developing type 2 diabetes later in life
Mental health
- Most new mothers experience anxiety during pregnancy and the postpartum period.
- No psychotropic drugs have been FDA-approved for use during pregnancy due to potential risks to the baby.
- Additionally, over half of new mothers are not routinely screened for mental health during pregnancy.
Approximately 20% of women experience mood disorders during pregnancy.
Singular Wings Solution
NI-CGM using biomarkers and AI
Non-invasive CGM
The world's first NI-CGM integrates digital biomarkers and AI algorithms to manage comorbidities such as obesity, mental health issues, and cardiovascular disease.
ECG Sensor, and software
We utilize a single wearable device for tracking daily glucose variations and monitoring mental anxiety levels. The app offers visual insights, highlighting potential health concerns.
PATENT PENDING
How does it works
Taiwan patent: 112150091
US patent: 18/396,724
EU patent: 24150461.2